Cargando…
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
Mood and anxiety disorders are the most prevalent psychiatric conditions and are exacerbated by stress. Recent studies have suggested cyclooxygenase-2 (COX-2) inhibition could represent a novel treatment approach or augmentation strategy for affective disorders including anxiety disorders and major...
Autores principales: | Gamble-George, Joyonna Carrie, Baldi, Rita, Halladay, Lindsay, Kocharian, Adrina, Hartley, Nolan, Silva, Carolyn Grace, Roberts, Holly, Haymer, Andre, Marnett, Lawrence J, Holmes, Andrew, Patel, Sachin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862754/ https://www.ncbi.nlm.nih.gov/pubmed/27162170 http://dx.doi.org/10.7554/eLife.14137 |
Ejemplares similares
-
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation
por: Hermanson, Daniel J., et al.
Publicado: (2013) -
Endocannabinoid signalling modulates susceptibility to traumatic stress exposure
por: Bluett, Rebecca J., et al.
Publicado: (2017) -
Structural and Chemical Biology of the Interaction
of Cyclooxygenase with Substrates and Non-Steroidal Anti-Inflammatory
Drugs
por: Rouzer, Carol A., et al.
Publicado: (2020) -
Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling Pathways
por: Rouzer, Carol A., et al.
Publicado: (2011) -
Cyclooxygenase-2 inhibition reduces anxiety-like behavior and normalizes enhanced amygdala glutamatergic transmission following chronic oral corticosterone treatment
por: Morgan, Amanda, et al.
Publicado: (2019)